These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 28314284)
21. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients. Myśliwiec H; Baran A; Harasim-Symbor E; Choromańska B; Myśliwiec P; Milewska AJ; Chabowski A; Flisiak I Arch Dermatol Res; 2017 Mar; 309(2):79-86. PubMed ID: 27988894 [TBL] [Abstract][Full Text] [Related]
22. Emerging Roles of Ceramides in Breast Cancer Biology and Therapy. Pal P; Atilla-Gokcumen GE; Frasor J Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232480 [TBL] [Abstract][Full Text] [Related]
23. Novel Insight into the Serum Sphingolipid Fingerprint Characterizing Longevity. Barbacini P; Torretta E; Arosio B; Ferri E; Capitanio D; Moriggi M; Gelfi C Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269570 [TBL] [Abstract][Full Text] [Related]
24. Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer. Jang SW; Park WJ; Min H; Kwon TK; Baek SK; Hwang I; Kim S; Park JW Oncol Rep; 2018 Dec; 40(6):3489-3500. PubMed ID: 30272337 [TBL] [Abstract][Full Text] [Related]
25. Endocannabinoid and ceramide levels are altered in patients with colorectal cancer. Chen L; Chen H; Li Y; Li L; Qiu Y; Ren J Oncol Rep; 2015 Jul; 34(1):447-54. PubMed ID: 25975960 [TBL] [Abstract][Full Text] [Related]
26. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa. Dany M; Elston D J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069 [TBL] [Abstract][Full Text] [Related]
27. Regulation of Serum Sphingolipids in Andean Children Born and Living at High Altitude (3775 m). Barbacini P; Casas J; Torretta E; Capitanio D; Maccallini G; Hirschler V; Gelfi C Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212599 [TBL] [Abstract][Full Text] [Related]
28. Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment. Ng TW; Ooi EM; Watts GF; Chan DC; Meikle PJ; Barrett PH J Clin Endocrinol Metab; 2015 Jun; 100(6):2497-501. PubMed ID: 25816050 [TBL] [Abstract][Full Text] [Related]
29. Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry. Sullards MC Methods Enzymol; 2000; 312():32-45. PubMed ID: 11070861 [TBL] [Abstract][Full Text] [Related]
30. Ceramides Profile Identifies Patients with More Advanced Stages of Colorectal Cancer. Markowski AR; Błachnio-Zabielska AU; Guzińska-Ustymowicz K; Markowska A; Pogodzińska K; Roszczyc K; Zińczuk J; Zabielski P Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32325909 [TBL] [Abstract][Full Text] [Related]
31. Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages. Abdulla MH; Valli-Mohammed MA; Al-Khayal K; Al Shkieh A; Zubaidi A; Ahmad R; Al-Saleh K; Al-Obeed O; McKerrow J Oncol Rep; 2017 Jun; 37(6):3175-3180. PubMed ID: 28440429 [TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics. Holm M; Saraswat M; Joenväärä S; Ristimäki A; Haglund C; Renkonen R PLoS One; 2018; 13(4):e0195354. PubMed ID: 29630649 [TBL] [Abstract][Full Text] [Related]
33. Quantification of sphingosine derivatives in human platelets: inducible formation of free sphingosine. Hisano N; Yatomi Y; Fujino MA; Igarashi Y; Kume S; Ozaki Y J Biochem; 1998 Feb; 123(2):263-8. PubMed ID: 9538201 [TBL] [Abstract][Full Text] [Related]
34. Vitamin D Supplementation Enhances C18(dihydro)ceramide Levels in Type 2 Diabetes Patients. Koch A; Grammatikos G; Trautmann S; Schreiber Y; Thomas D; Bruns F; Pfeilschifter J; Badenhoop K; Penna-Martinez M Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714882 [TBL] [Abstract][Full Text] [Related]
35. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide. Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668 [TBL] [Abstract][Full Text] [Related]
37. Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis. Allan D Biochem J; 2000 Feb; 345 Pt 3(Pt 3):603-10. PubMed ID: 10642519 [TBL] [Abstract][Full Text] [Related]
38. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study. Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240 [TBL] [Abstract][Full Text] [Related]
39. Low serum sphingolipids in children with attention deficit-hyperactivity disorder. Henríquez-Henríquez MP; Solari S; Quiroga T; Kim BI; Deckelbaum RJ; Worgall TS Front Neurosci; 2015; 9():300. PubMed ID: 26379487 [TBL] [Abstract][Full Text] [Related]
40. Ceramide metabolite, not intact ceramide molecule, may be responsible for cellular toxicity. Tserng KY; Griffin RL Biochem J; 2004 Jun; 380(Pt 3):715-22. PubMed ID: 14998372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]